📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Editorial: Trajectory of soluble programmed cell death protein-1 and ligand-1 in HBV-infected individuals treated with pegylated interferon-implications for stopping rules and the HBV cure programme. (2024)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/apt.18142

PubMed Identifier: 39021047

Publication URI: http://europepmc.org/abstract/MED/39021047

Type: Journal Article/Review

Volume: 60

Parent Publication: Alimentary pharmacology & therapeutics

Issue: 5

ISSN: 0269-2813